SCOTT M KNUDSEN: Open Payments
NPI 1629651666 · MOUNTAIN HOME, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 21 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $280 · 2025 $486
Food & beverage: $486
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $219 |
| Exact Sciences Corporation | 2 | $50 |
| Lilly USA, LLC | 2 | $46 |
| Novo Nordisk Inc | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $18 |
| PFIZER INC. | 1 | $16 |
Products named: UBRELVY, Cologuard Collection Kit, MOUNJARO, QULIPTA, Ozempic, FANAPT, FARXIGA, JARDIANCE.
Industry payments across ID — which companies pay providers there.
